These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 23406869

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Assessment of nailfold capillaroscopy in systemic sclerosis by different optical magnification methods.
    Mazzotti NG, Bredemeier M, Brenol CV, Xavier RM, Cestari TF.
    Clin Exp Dermatol; 2014 Mar; 39(2):135-41. PubMed ID: 24330076
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Nailfold capillary abnormalities are prevalent in sclerodermoid graft-versus-host disease and readily detected with dermatoscopy.
    Akay BN, Sanli H, Topcuoglu P, Arat M, Akyol A.
    Br J Dermatol; 2010 May; 162(5):1076-82. PubMed ID: 20222922
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The influence of hydration and heating on visualisation of nailfold capillaries in patients with systemic sclerosis.
    Sheikh ASF, Wilkinson J, MacIver I, Manning J, Murray A, Dinsdale G, Herrick AL.
    Microvasc Res; 2021 Jul; 136():104170. PubMed ID: 33839110
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Capillary density: An important parameter in nailfold capillaroscopy.
    Emrani Z, Karbalaie A, Fatemi A, Etehadtavakol M, Erlandsson BE.
    Microvasc Res; 2017 Jan; 109():7-18. PubMed ID: 27614146
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Nailfold capillaroscopic parameters and skin telangiectasia patterns in patients with systemic sclerosis.
    Pizzorni C, Giampetruzzi AR, Mondino C, Facchiano A, Abeni D, Paolino S, Ruaro B, Smith V, Sulli A, Cutolo M.
    Microvasc Res; 2017 May; 111():20-24. PubMed ID: 27989404
    [Abstract] [Full Text] [Related]

  • 36. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
    Cutolo M, Pizzorni C, Tuccio M, Burroni A, Craviotto C, Basso M, Seriolo B, Sulli A.
    Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Scleroderma capillary pattern identification using texture descriptors and ensemble classification.
    Schaefer G, Krawczyk B, Doshi NP, Merla A.
    Annu Int Conf IEEE Eng Med Biol Soc; 2013 Jun; 2013():5473-6. PubMed ID: 24110975
    [Abstract] [Full Text] [Related]

  • 39. A study of scleroderma in South Australia: prevalence, subset characteristics and nailfold capillaroscopy.
    Chandran G, Smith M, Ahern MJ, Roberts-Thomson PJ.
    Aust N Z J Med; 1995 Dec; 25(6):688-94. PubMed ID: 8770332
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.